首页> 外文期刊>Photodermatology, photoimmunology and photomedicine >The course of anticoagulation after extracorporeal photochemotherapy.
【24h】

The course of anticoagulation after extracorporeal photochemotherapy.

机译:体外光化学疗法后的抗凝过程。

获取原文
获取原文并翻译 | 示例
           

摘要

During extracorporeal photochemotherapy (ECP) heparin is added to the extracorporeal circulation to avoid clotting. It has not been investigated whether and to what extend this procedure influences coagulation in patients after ECP. In this study activated partial thrombaplastin time (aPTT) and anti-factor Xa were monitored for up to 4 h after ECP in 10 patients. We found that anticoagulation followed the typical course of intravenously applied heparin: immediately after reinfusion anti-Xa was high (>1 IU/ml) and aPTT was prolonged to more than 180 s followed by a rapid decline and reaching normal values within 3-4 h in all patients. We conclude that anticoagulation and increased risk of bleeding after ECP is confined to a short period immediately following treatment. Physicians using ECP should be aware of the course of anticoagulation associated with this treatment.
机译:在体外光化学疗法(ECP)期间,将肝素添加到体外循环中以避免凝结。尚未研究该程序是否影响ECP后患者的凝血,以及在何种程度上影响凝血。在这项研究中,对10例患者进行了ECP后长达4小时的局部凝血激活时间(aPTT)和Xa抗因子监测。我们发现抗凝遵循静脉内施用肝素的典型过程:在重新输注后,抗Xa值很高(> 1 IU / ml),aPTT延长至超过180 s,然后迅速下降并在3-4天内达到正常值h在所有患者中。我们得出的结论是,ECP后的抗凝治疗和出血风险增加仅限于治疗后的短期内。使用ECP的医师应注意与该治疗有关的抗凝过程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号